肝豆状核变性患者角膜K-F环与临床病情程度关系探讨*

doi:10.3969/j.issn.1672-5069.2024.01.037

Abstract

Chen Fenfen, Hu Fengyun, Cao Xiaoli, et al. Response to D-penicillamine treatment in patients with Wi1son's disease and different degree of Kayser-Fleischer ring[J]. Journal of Practical Hepatology, 2024, 27(1): 145-147.

References

[1] Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers, 2018, 4(1): 21.
[2] 中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南(2021年). 中华神经科杂志, 2021, 54(4): 310-319.
[3] 中华医学会神经病学分会帕金森病暨运动障碍学组, 中华医学会神经病学分会神经遗传病学组. 肝豆状核变性的诊断和治疗指南. 中华神经科杂志, 2008, 41(8): 566-569.
[4] 杨锡强,易著文,儿科学,6版,北京:人民卫生出版社,2004:173.
[5] 黄芳,黄丽,李洵桦.角膜K-F环对肝豆状核变性的诊断价值.中国现代医学杂志,2013,23(3):44-47.
[6] 罗继红,梁娜.角膜K-F环与WD关系的临床分析.中西医结合肝病杂志,2011,21(4):241-242.
[7] Guttmann S,Bernick F,Naorniakowska M,et al. Functional characterization of novel ATP7B variants for diagnosis of Wilson disesas. Front Pediatr,2018,6:106.
[8] Bandmann O,Weiss KH,Kaler SG. Wi1son's disease and other neurological copper disorders. Lancet Neurol,2015,14(1):103-113.
[9] Merle U,Schaefer M,Ferenci P,et al.Clinical presentation,diagnosis and long-term outcome of Wilson’s disease:a cohort study .Gut,2007,56(1):115-120.
[10] 霍丽君,廖瑞瑞,陈雪梅.Wilson病的眼病表现.中华神经科杂志,2008,44(2):128-130.
[11] European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol,2012,56(3):671-685.
[12] Palumbo CS, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med Med,2019,7(Suppl 2):S65.
[13] Herrera-Quiñones G, Da Fieno AM, Compta Y, et al. Considerations for optimizing Wilson's disease patients' long-term follow-up. Gastroenterol Hepatol,2022,45(2):146-154.
[14] Polishchuk EV,Concilli M,Iacobacci S,et al.Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.Del Cell,2014,29(6):686-700.
[15] Socha P, Janczyk W, Dhawan A, et al. Wilson’s disease in children: A position paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr,2018,66(2):334-344.
[16] Mohr I, Weiss KH. Biochemical markers for the diagnosis and monitoring of Wilson Disease. Clin Biochem Rev,2019,40(2):59-77.
[17] 张亦瑾,高学松等.儿童与成人肝豆状核变性患者临床特征和生存分析.实用肝脏病杂志,2023,26(4):520-523.
[18] Xie JJ, Wu ZY. Wilson disease in China. Neurosci Bull,2017,33(3):323-330.

Response to D-penicillamine treatment in patients with Wi1son's disease and different degree of Kayser-Fleischer ring

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Jin Keke, Ding Huiguo. Risk and anticoagulation management of cirrhotic patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2024, 27(1): 3-6.
[2]	Zhang Ming. Portal vein thrombosis in cirrhotic patients: the states of the art [J]. Journal of Practical Hepatology, 2024, 27(1): 11-15.
[3]	Tang Zhiquan, Yang Ting, Li Kailing. Impact of hyperuricemia on virological response to sofosbuvir/daratavir therapy in patients with chronic hepatitis C [J]. Journal of Practical Hepatology, 2024, 27(1): 28-31.
[4]	Wang Yan, Han Jun, Yang Meirong. Twenty-four month follow-up for patients with chronic hepatitis C after sustained virological response to different DAAs treatment regimen [J]. Journal of Practical Hepatology, 2024, 27(1): 32-35.
[5]	Huang Jiejie, Zheng Qian, Lyu Rui, et al. Efficacy of liraglutide and atorvastatin calcium combination in treating patients with nonalcoholic fatty liver diseases complicated with abnormal glucolipid metabolism [J]. Journal of Practical Hepatology, 2024, 27(1): 36-39.
[6]	Yan Yuting, Jia Gui, Meng Qin, et al. Thyroid functions and their impact on response to standardized therapy in patients with autoimmune hepatitis and primary biliary cholangitis [J]. Journal of Practical Hepatology, 2024, 27(1): 52-55.
[7]	Li Xinli, Qin Changjiang, Yin Fangfang. Efficacy of terlipressin treatment after endoscopic variceal ligation in the treatment of patients with liver cirrhosis complicated by esophageal and gastric variceal bleeding [J]. Journal of Practical Hepatology, 2024, 27(1): 76-79.
[8]	Ye Mengmeng, Deng Zerun, Zhang Tao. Improved benefit of camrelizumab and apatinib combination in the treatment of patients with advanced hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2024, 27(1): 96-100.
[9]	Fan Ming, Yang Long, Jin Liang, et al. Different hepatic inflow occlusion techniques during laparoscopic hepatectomy in treatment of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2024, 27(1): 101-104.
[10]	Bao Tianshu, Du Yemu, Yao Shanwen, et al. Short-term efficacy of three-dimensional conformal radiotherapy in patients with primary liver cancer [J]. Journal of Practical Hepatology, 2024, 27(1): 105-108.
[11]	Zheng Hao, Wang Hongjian, Liu Jingjing. Clinical features of Klebsiella Pneumonia-induced bacterial liver abscess [J]. Journal of Practical Hepatology, 2024, 27(1): 121-124.
[12]	Jia Yongli, Wang Pengchuan, Guo Wei, et al. Efficacy of ultrasound-guided injection of absolute ethanol or lauromacrogol in treating patients with hepatic cysts [J]. Journal of Practical Hepatology, 2024, 27(1): 125-128.
[13]	Hu Guangming, Zhou Tao, Xiao Jie, et al. Combination of laparoscopic cholecystectomy and laparoscopic common bile duct exploration in treatment of patients with gallbladder and common bile duct stones: Is the nasobiliary drainage superior to T-tube drainage? [J]. Journal of Practical Hepatology, 2024, 27(1): 129-132.
[14]	Wang Dongjun, Zhang Chunyan, Chao Xiangsong, et al. Evaluation of surgical risk in patients with liver cirrhosis and acute cholecystitis by cholecystitis severity grading and MELD scores [J]. Journal of Practical Hepatology, 2024, 27(1): 133-136.
[15]	Xu Yuan, Zhang Bo. Application of laparoscopic cholecystectomy under guidance of indocyanine greennear infrared fluorescence in treatment of patients with gallstones [J]. Journal of Practical Hepatology, 2024, 27(1): 141-144.